NorthWest Biotherapeutics Inc (NWBO)

[LessIsMore]

there is no contract NWBO can PR YET because the condition is not met YET

This is just pure speculation, it's also speculation that NWBO CAN PR the contingent contract.

The problem here is that LP/LG have zero credibility with the majority of investors, time and again they have used legalese which allows the internet army (dolphin, both DD, fake Dr, bioharm, etc...) to dot connect to their hearts content. NWBO is not deserving of the benefit of the doubt, those who believe they do should not be investing in the stock market.

Around 5 years ago Lyin' Les Goldman used disgraced blogger Chris LaCoursiere to pump an imminent contract with BP which would include an upfront payment and contingent milestone payments. The internet army (see main culprits above) ran with it for weeks. Finally, the news was released in which Merck had agreed to supply Keytruda free of charge for an upcoming combo trial. No cash and no contingent payments (of course the internet army proclaimed this as great news because Merck was just waiting to buy NWBO, why would they throw money at a takeover).

Just a few days ago Merck announced a license agreement, this is how news should be delivered. Please notice that milestone payments include a contingency on regulatory approval. The bottom line is that NWBO could give specifics on this contract but chose not to. Why they chose not to is subject to speculation. We disagree on why they chose not to which is fine, that's what makes a market there DD. Best of luck to you!

Under the agreement, LaNova has granted Merck an exclusive global license to develop, manufacture and commercialize LM-299. LaNova will receive an upfront payment of $588 million. LaNova is also eligible to receive up to $2.7 billion in milestone payments associated with the technology transfer, development, regulatory approval and commercialization of LM-299 across multiple indications.